Approval · Notice of Compliance 12503 · 2011
ACTEMRA: Notice of Compliance 12503
Issued July 21, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12503
- Date
- July 21, 2011
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing process
- Therapeutic class
- Interleukin Receptor Inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTEMRA | Not yet assigned | — |
Medicinal ingredients
- TOCILIZUMAB 80 MG per 4ML
- TOCILIZUMAB 200 MG per 10ML
- TOCILIZUMAB 400 MG per 20ML